Patients’ refusal to consent to storage and use of samples in Swedish biobanks: cross sectional studyBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a345 (Published 10 July 2008) Cite this as: BMJ 2008;337:a345
- Linus Johnsson, student1,
- Mats G Hansson, professor1,
- Stefan Eriksson, senior researcher1,
- Gert Helgesson, senior researcher2
- 1Centre for Research Ethics and Bioethics, Uppsala University, Uppsala Science Park, SE-751 85 Uppsala, Sweden
- 2Unit for Bioethics, LIME, Karolinska Institutet, Berzelius väg 3, SE-171 77 Stockholm
- Correspondence to: L Johnsson
- Accepted 8 May 2008
Objectives To estimate how many people object to storage of biological samples collected in health care in Sweden and to their use in research and how many withdraw previous consent.
Design Cross sectional study of register data.
Setting Biobanks used in Swedish health care, 2005-6.
Population Data on refusal to consent were obtained for 1.4 million biobank samples per year from 20 of 21 counties.
Main outcome measures Rates of preliminary refusal to consent, confirmed refusal, and withdrawal of consent.
Results Patients refused consent to either storage or use of their samples in about 1 in 690 cases; about 1 in 1600 confirmed their decision by completing a dissent form. Rather than having the samples destroyed, about 1 in 6200 patients wanted to restrict their use. Of those who had previously consented, about 1 in 19 000 withdrew their consent.
Conclusions Refusal to consent to biobank research in Sweden is rare, and the interests of individuals and research interests need not be at odds. The Swedish healthcare organisation is currently obliged to obtain either consent or refusal to each potential use of each sample taken, and lack of consent to research is used as the default position. A system of presumed consent with straightforward opt out would correspond with people’s attitudes, as expressed in their actions, towards biobank research.
This study was conducted as part of the AutoCure project of the EU Sixth Framework Programme.
Contributors: LJ collected and analysed data and wrote the paper. All authors contributed equally to study design and revision of critical intellectual content and approved the final version. LJ is guarantor.
Funding: AutoCure project within the EU Sixth Framework Programme.
Competing interests: None declared.
Ethical approval: Not required.
Provenance and peer review: Not commissioned; externally peer reviewed.